PT  - JOURNAL ARTICLE
AU  - W Z Yang
AU  - A Begleiter
AU  - J B Johnston
AU  - L G Israels
AU  - M R Mowat
TI  - Role of glutathione and glutathione S-transferase in chlorambucil resistance.
DP  - 1992 Apr 01
TA  - Molecular Pharmacology
PG  - 625--630
VI  - 41
IP  - 4
4099  - http://molpharm.aspetjournals.org/content/41/4/625.short
4100  - http://molpharm.aspetjournals.org/content/41/4/625.full
SO  - Mol Pharmacol1992 Apr 01; 41
AB  - A chlorambucil (CLB)-resistant cell line, N50-4, was developed from the established mouse fibroblast cell line NIH 3T3, by multistep drug selection. The mutant cells exhibited greater than 10-fold resistance to CLB. Alterations in GSH and glutathione S-transferase (GST) were found in CLB-resistant variants. A 7-10-fold increase in cellular GSH content and a 3-fold increase in GST activity were detected in N50-4 cells, compared with parental cells, as determined by enzymatic assays. An increase in steady state levels of the GST-alpha isozyme mRNA was found in the CLB-resistant cells, as analyzed by Northern blotting. No GST gene amplification or rearrangement was shown by Southern blot analysis. To test the relative roles of GSH and GST in CLB resistance, a number of GSH- and GST-blocking agents were used. The CLB toxicity was significantly enhanced in N50-4 cells by administration of either the GSH-depleting agent buthionine sulfoximine or the GST inhibitors ethacrynic acid or indomethacin. The resistance to CLB cytotoxicity in N50-4 cells, however, was still significantly higher than that of parental cells. The resistance of N50-4 cells to CLB was almost completely abolished by combination pretreatment yielding both GSH depletion and GST inhibition. The results indicate that both increased cellular GSH content and increased GST activity play major roles in CLB resistance in N50-4 mutant cells.